M-End DMX Interactions
There are 588 drugs known to interact with M-End DMX (dexbrompheniramine/dextromethorphan/pseudoephedrine), along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 95 are major, 484 are moderate, and 9 are minor.
- View all 588 medications that may interact with M-End DMX
- View M-End DMX alcohol/food interactions (2)
- View M-End DMX disease interactions (10)
Most frequently checked interactions
View interaction reports for M-End DMX (dexbrompheniramine / dextromethorphan / pseudoephedrine) and the medicines listed below.
- Abilify (aripiprazole)
- acetylcysteine
- Adderall (amphetamine / dextroamphetamine)
- Airborne (multivitamin with minerals)
- albuterol
- allopurinol
- alpha-lipoic acid
- alprazolam
- Ambien (zolpidem)
- amino acids
- amitriptyline
- amoxicillin
- amoxicillin / clavulanate
- baclofen
- dexamethasone
- duloxetine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- fluticasone
- gabapentin
- levocetirizine
- montelukast
- Norco (acetaminophen / hydrocodone)
- Soma (carisoprodol)
- tramadol
- triamcinolone topical
- turmeric
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zantac (ranitidine)
M-End DMX alcohol/food interactions
There are 2 alcohol/food interactions with M-End DMX (dexbrompheniramine / dextromethorphan / pseudoephedrine).
M-End DMX disease interactions
There are 10 disease interactions with M-End DMX (dexbrompheniramine / dextromethorphan / pseudoephedrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
More about M-End DMX (dexbrompheniramine / dextromethorphan / pseudoephedrine)
- M-End DMX consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.